EGFR and carcinoma: Our previous demonstration that CD147 expression in epithelial mammary tumor cells is increased by the EGF/EGFR system [69] suggests that the activation of EGFR signaling may account, at least partially, to the increased expression of CD147 observed in most carcinomas and to the therapeutic potential of EGFR inhibitors.